Dr. Burtness on Immunotherapy Resistance in Head and Neck Cancer

Barbara Burtness, MD, professor of medicine, Yale Cancer Center, discusses immunotherapy resistance in head and neck cancer.

Immunotherapy is producing durable responses across malignancies, but there are still many patients who do not respond.

Burtness asks if the community has turned their back on targeted therapy too quickly. There may be promise in synthetic lethal approaches with targeted therapies, she adds.